Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more

White Paper: Health Economic Evidence Requirements for Medical Devices in Europe

Get insights from MTRC White Papers to discover health economic evidence requirements and best practices for market access in the EU5

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EU HTA Publication Digest: Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA Framework

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Mezei et al. examined regulatory and methodological barriers affecting digital health technologies (DHTs), drawing on surveys, interviews, and focus groups with developers from ten European countries. The authors reported persistent challenges, including limited transparency in reimbursement processes, fragmented HTA requirements, and misalignment between traditional evidence models and the iterative nature of DHT development. Their findings highlighted the need for a harmonized European HTA framework that integrates real-world evidence, accommodates agile development cycles, and reduces uncertainty for developers.

Access the full-text article here.